
|Articles|December 1, 2004
New ventures may help make up for lost reimbursement
San Diego--Searching for ways to recoup lost revenue from outpatient prostate cancer therapy, urologists have turned to a variety of non-traditional income producers, ranging from CT scanning to processing of biopsy specimens.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Study suggests potential diuretic effect with nadofaragene firadenovec
2
The UroOnc Minute: MDT for Oligometastatic Prostate Cancer, with Chad Tang, MD
3
Published data show DFS benefit with aglatimagene besadenovec in localized prostate cancer
4
Clint Bahler, MD, reflects on precision medicine and focal therapy highlights at AUA 2026
5











